0
Your cart

Your cart is empty

Books > Medicine > Other branches of medicine > Nuclear medicine

Buy Now

Biological Models in Radiopharmaceutical Development (Paperback, Softcover reprint of the original 1st ed. 1996) Loot Price: R1,471
Discovery Miles 14 710
Biological Models in Radiopharmaceutical Development (Paperback, Softcover reprint of the original 1st ed. 1996): R.M. Lambrecht

Biological Models in Radiopharmaceutical Development (Paperback, Softcover reprint of the original 1st ed. 1996)

R.M. Lambrecht

Series: Developments in Nuclear Medicine, 27

 (sign in to rate)
Loot Price R1,471 Discovery Miles 14 710 | Repayment Terms: R138 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Donate to Against Period Poverty

Radiophannaceuticals labeled with short-lived radionuclides are utilized to unravel biochemical processes, and to diagnosis and treat diseases of the living body are-developed through extensive evaluation in ~iological models. 'fhC first attempt to compile information was a volume entitled ANIMAL MODELS IN RADIOTRACER DESIGN that was edited by William C. Eckelman and myself in 1983. The volume had a focus on the animal models that investigators were using in order to design radiotracers that displayed in vivo selectivity as measured by biodistribution and pharmacokinetic studies. A concern in the early days of nuclear medicine was species differences. Often a series of labeled compounds were evaluated in a several different animal models in order to gain confidence that the selected radiotracer would behave appropriately in humans. During the past 12 years there have been remarkable advances in molecular genetics, molecular biology, synthetic radiopharmaceutical chemistry, molecular modeling and visualization, and emission tomography. Biological models can now be selected that are better defined in terms of molecular aspects of the disease process. The development of high resolution PET and SPET for clinical applications facilitates the development of new radiopharmaceuticals by the use of models to quantitatively evaluate drug effects, and progression of disease, and hence to arrive at better diagnosis and treatments for animals and humans. With these advances there is an effective use of biological models, and the refinement of alternatives for the development of new radiophannaceuticals.

General

Imprint: Springer
Country of origin: Netherlands
Series: Developments in Nuclear Medicine, 27
Release date: September 2011
First published: 1996
Authors: R.M. Lambrecht
Dimensions: 240 x 160 x 15mm (L x W x T)
Format: Paperback
Pages: 272
Edition: Softcover reprint of the original 1st ed. 1996
ISBN-13: 978-9401065580
Categories: Books > Medicine > Other branches of medicine > Nuclear medicine
Books > Professional & Technical > Veterinary science > General
Books > Medicine > General issues > Medical equipment & techniques > Medical laboratory testing & techniques
Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Other branches of medicine > Medical imaging > Radiology
LSN: 9401065586
Barcode: 9789401065580

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners